SpectraScience, Inc.

Company receives notice that European patent will be issued for optical biopsy system

Published in Lab Law Weekly, January 27th, 2006

SpectraScience, Inc. (SCIE) announced that it has received notification from the European Patent Office that a patent will be issued for its "Optical Biopsy Forceps and Method of Diagnosing Tissue."

The company has developed its proprietary WavStat optical biopsy system for use by physicians in diagnosing tissue to be normal, precancerous, or cancerous.

The WavStat system is approved by the U.S. Food and Drug Administration (FDA) for use in detecting cancer in the colon. Other applications for detecting precancers in the throat, sometimes called Barrett's esophagus, are being tested in a clinical trial.

Cancer of the esophagus is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2006-01-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry